ABVC BioPharma

"This new study will integrate AI-driven solutions to address the significant challenge of depression among cancer patients, a condition that often complicates treatment and adversely affects overall quality of life."

ABVC - ABVC BioPharma's CEO Discusses New Drug Development... --News Direct-- After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder ABVC BioPharma Inc..

All-Natural Treatment for Major Depressive Disorder (MDD) Explained. Struggling with MDD? Discover how ABV-1504, an all-natural solution, can help manage symptoms effectively without severe adverse side effects. This video introduces the challenges of living with MDD and highlights the benefits of our innovative treatment. Learn more about how ABV-1504 can improve your mental health naturally and safely. Watch now to find out more!

All Natural Treatment for MDD ABV-1504 All-Natural Treatment for Major Depressive Disorder (MDD) | ABV-1504 Explained. Struggling with MDD? Discover how ABV-1504, an all-natural solution, can help...

"We believe that our combined expertise in biopharmaceuticals and AI technology will enable us to develop more effective treatments for depression in cancer patients, ultimately improving their quality of life." - from our C.E.O.

ABVC and AiBtl to Launch a New Clinical Study on Depression in Cancer Patients Using AI FREMONT, CA - (NewMediaWire) - July 9, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that afte...

We would like to congratulate our subsidiary AiBtl on their acquisition of TTLife.

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share FREMONT, CA - (NewMediaWire) - April 18, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, an...